Brief: Allovir Reports Full-Year 2022 Financial Results And 2023 Outlook

Kalaris Therapeutics

15/02/2023 13:16

Feb 15 (Reuters) - Allovir Inc  ALVR.O :
    * ALLOVIR REPORTS FULL-YEAR 2022 FINANCIAL RESULTS AND 2023
OUTLOOK
    * ALLOVIR INC- STRONG CASH POSITION, WITH $233.8 MILLION AS
OF
YEAR-END 2022
    * ALLOVIR INC - FOR FY 2023, EXPECTS OPERATING EXPENSES TO
BE IN
RANGE OF $150 MILLION TO $170 MILLION, EXCLUDING NON-CASH
EXPENSES

Source text for Eikon:  ID:nBw3CnfYva 
Further company coverage:  ALVR.O 
 ((Reuters.Briefs@thomsonreuters.com;;))